Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women: Efficacy of Flibanserin in the VIOLET Study

Journal of Sexual Medicine

Volumn 9, Issue 4, 2012, Pages 1074-1085

  Derogatis, Leonard R ^a   Komer, Lawrence ^b,g   Katz, Molly ^c   Moreau, Michèle ^d   Kimura, Toshio ^e   Garcia Jr , Miguel ^e   Wunderlich, Glen ^f   Pyke, Robert ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b The Centre for Women's Health   (Canada)

^c Katz and Kade Inc   (United States)

^d INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^f BOEHRINGER INGELHEIM CANADA LTD   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Distress; Flibanserin; HSDD; Hypoactive sexual desire disorder; Patient reported outcomes; Premenopausal women; PRO

Indexed keywords

FLIBANSERIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; FATIGUE; FEMALE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INSOMNIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEXUAL FUNCTION; SINUSITIS; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION;

EID: 84859264681     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02626.x     Document Type: Article

References (25)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Text revision. Washington, DC: American Psychiatric Press; 2000.
2. Bachmann G. Female sexuality and sexual dysfunction: Are we stuck on the learning curve? J Sex Med 2006;3:639-45.
3. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009;6:1549-60.
4. Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women's sexual desire and arousal disorders. J Sex Med 2010;7:586-614.
5. Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: Current status and future directions. J Sex Res 2009;46:121-42.
6. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
7. Borsini F, Evans K, Jason K, Rohde F, Alexander B, Pollentier S. Pharmacology of flibanserin. CNS Drug Rev 2002;8:117-42.
8. Marazziti D, Palego L, Giromella A, Mazzoni MR, Borsini F, Mayer N, Naccarato AG, Lucacchini A, Cassano GB. Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain. Int J Neuropsychopharmacol 2002;5:131-40.
9. Kennedy SH. Flibanserin: Initial evidence of efficacy on sexual dysfunction, in patients with Major Depressive Disorder. J Sex Med 2010;7:3449-59.
10. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, Woods N. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-72.
11. DeRogatis LR, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the Female Sexual Distress Scale-Revised for assessing distress in women with Hypoactive Sexual Desire Disorder. J Sex Med 2008;5:357-64.
12. Clayton AH, Goldmeier D, Nappi RE, Lewis-D'Agostino DJ, Wunderlich G, Pyke R. Validation of the Sexual Interest and Desire Inventory-Female (SIDI-F) in Hypoactive Sexual Desire Disorder. J Sex Med 2010;7:3918-28.
13. Beck A, Steer R, Brown G. Manual for the Beck Depression Inventory-II. San Antonio, Texas: The Psychological Corporation; 1996.
14. Beck AT, Steer RA. Manual for Beck Scale for Suicide Ideation. San Antonio, TX: The Psychological Corporation; 1991.
15. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R, Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
16. Hochberg Y. A sharper Bonferroni procedure for multiple test of significance. Biometrika 2010;75:800-2.
17. US Food and Drug Administration. Draft guidance for industry-Female sexual dysfunction: Clinical development of drug products for treatment. 2000. Available at: (accessed March 16, 2010.
18. Tignol J, Clayton AH, van Lunsen R, Nappi RE, Goldmeier D, Lewis-D'Agostino DJ, Pyke R, Wunderlich G. Using e-Diaries to measure sexual desire in women with HSDD. J Sex Med 2008;5:53.
19. Clayton AH, Dennerstein L, Fisher WA, Kingsberg SA, Perelman MA, Pyke RE. Standards for clinical trials in sexual dysfunction in women: Research designs and outcomes assessment. J Sex Med 2010;7:541-60.
20. Revicki D, Margolis MK, Bush EN, DeRogatis L, Hanes V. Content validity of the Female Sexual Function Index (FSFI) in pre- and post-menopausal women with Hypoactive Sexual Desire Disorder (HSDD). J Sex Med 2011;8:2237-45.
21. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with Hypoactive Sexual Desire Disorder. J Sex Marital Ther 2003;29:39-46.
22. DeRogatis L, Pyke R, McCormack J, Hunter A, Harding G. Does the Female Sexual Distress Scale-Revised cover the feelings of women with HSDD? J Sex Med 2011;8:2810-5.
23. Allers KA, Dremencov E, Ceci A, Flik G, Ferger B, Cremers TI, Ittrich C, Sommer B. Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: A microdialysis study. J Sex Med 2010;7:1757-67.
24. Stahl SM, Sommer B, Allers KA. Multifunctional pharmacology of flibanserin: Possible mechanism of therapeutic action in hypoactive sexual desire disorder. J Sex Med 2011;8:15-27.
25. Clayton AH, Dennerstein L, Pyke R, Sand M. Flibanserin: A potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women. Womens Health (Lond Engl) 2010;6:639-53.